The emerging potential of interactive virtual reality in drug discovery. (2022)
Attributed to:
Nicotinic Ligand Development to Target Smoking Cessation and Gain a Molecular Level Understanding of Partial Agonism
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/17460441.2022.2079632
PubMed Identifier: 35638298
Publication URI: http://europepmc.org/abstract/MED/35638298
Type: Journal Article/Review
Volume: 17
Parent Publication: Expert opinion on drug discovery
Issue: 7
ISSN: 1746-0441